Novo Nordisk expands into hair loss treatments, leveraging hormone expertise

Novo Nordisk, maker of Ozempic and Wegovy, is targeting the hair loss treatment market as a new growth area beyond diabetes and obesity. The company aims to leverage its hormone expertise and direct patient distribution channels. This marks a strategic diversification, though specific pipeline details remain undisclosed.